Family history of liver cancer and hepatocellular carcinoma

Hepatology

Volumn 55, Issue 5, 2012, Pages 1416-1425

  Turati, Federica ^a,b   Edefonti, Valeria ^b   Talamini, Renato ^c   Ferraroni, Monica ^b   Malvezzi, Matteo ^a,b,d   Bravi, Francesca ^a,b   Franceschi, Silvia ^e   Montella, Maurizio ^f   Polesel, Jerry ^c   Zucchetto, Antonella ^c   La Vecchia, Carlo ^a,b,g   Negri, Eva ^a   Decarli, Adriano ^b,d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; ITALY; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK FACTOR; SEX; SMOKING;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PEDIGREE; PREVALENCE; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84859948242     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24794     Document Type: Article

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
3. Montella M, Serraino D, Crispo A, Romano N, Fusco M, Goedert JJ. Infection with human herpes virus type 8 in an area at high prevalence for hepatitis C virus infection in southern Italy. J Viral Hepat 2004; 11: 268-270.
4. Montella M, Crispo A, Grimaldi M, Angeletti C, Amore A, Ronga D, Sabbatini M, et al. Prevalence of hepatitis C virus infection in different population groups in southern Italy. Infection 2005; 33: 9-12.
5. Stuver S, Trichopoulos D: Cancer of the liver and biliary tract. In: Adami H-O, Hunter D, Trichopoulos D, eds. Cancer Epidemiology, 2nd ed. New York: Oxford Universiy Press; 2008: 308-332.
6. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347-354.
7. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92: 1159-1164.
8. Chen CH, Huang GT, Lee HS, Yang PM, Chen DS, Sheu JC. Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma. J Clin Gastroenterol 1998; 27: 236-239.
9. Mueller NE, Birmann BM, Parsonnet J, Schiffman MH, Stuver S. Infectious agents. In: Schottenfeld D, Fraumeni JJ, eds. Cancer Epidemiology and Prevention, 3rd ed. New York: Oxford Universiy Press; 2006: 507-548.
10. Hassan MM, Spitz MR, Thomas MB, Curley SA, Patt YZ, Vauthey JN, et al. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 2009; 50: 334-341.
11. Donato F, Gelatti U, Chiesa R, Albertini A, Bucella E, Boffetta P, et al. A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control 1999; 10: 417-421.
12. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90, 000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002; 11: 369-376.
13. Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006; 15: 683-689.
14. Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004; 110: 380-385.
15. Silberberg J, Fryer J, Wlodarczyk J, Robertson R, Dear K. Comparison of family history measures used to identify high risk of coronary heart disease. Genet Epidemiol 1999; 16: 344-355.
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
17. Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. HEPATOLOGY 2009; 49: 1563-1570.
18. Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 2003; 98: 1417-1422.
19. London WT, Evans AA, McGlynn K, Buetow K, An P, Gao L, et al. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995; 38: 155-161.
20. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. HEPATOLOGY 1999; 29: 697-702.
21. Liu TT, Fang Y, Xiong H, Chen TY, Ni ZP, Luo JF, et al. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World J Gastroenterol 2008; 14: 3059-3063.
22. Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 1992; 51: 509-514.
23. Tsukuma H, Hiyama T, Oshima A, Sobue T, Fujimoto I, Kasugai H, et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990; 45: 231-236.
24. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking, and familial tendency on hepatocellular carcinoma. HEPATOLOGY 1991; 13: 398-406.
25. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 209-212.
26. Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, et al. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett 2005; 229: 77-83.
27. Hsu LM, Huang YS, Yang SY, Chang FY, Lee SD. Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma. Anticancer Res 2006; 26: 3787-3791.
28. Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. HEPATOLOGY 1999; 30: 379-383.
29. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002; 98: 257-261.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
31. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
32. Ottawa Hospital Research Institute: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: Accessed August 7, 2008.
33. Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-357.
34. Larsson SC, Wolk A. Overweight, obesity, and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005-1008.
35. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-380.
36. Freedman RA, Garber JE. Family cancer history: healthy skepticism required. J Natl Cancer Inst 2011; 103: 776-777.
37. Bravi F, Bosetti C, Negri E, Lagiou P, La Vecchia C. Family history of cancer provided by hospital controls was satisfactorily reliable. J Clin Epidemiol 2007; 60: 171-175.
38. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114-122.
39. Mai PL, Garceau AO, Graubard BI, Dunn M, McNeel TS, Gonsalves L, et al. Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst 2011; 103: 788-797.
40. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 315-320.
41. Volk ML, Lok AS. Is family history of liver cancer a risk factor for hepatocellular carcinoma? J Hepatol 2009; 50: 247-248.